Navigation Links
CareFusion Receives Federal Data Encryption Certification for Alaris® Infusion System
Date:1/17/2012

SAN DIEGO, Jan. 17, 2012  /PRNewswire/ -- CareFusion today announced its Alaris System wireless security solution is the first and only infusion system to receive a new data encryption certification now required for infusion devices operating on U.S. Department of Veterans Affairs hospital networks.

(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)

The certification, known as Federal Information Processing Standard (FIPS) 140-2, certifies that the Alaris System is compliant with stringent wireless encryption and physical security requirements set by the National Institute of Standards and Technology (NIST). 

The NIST FIPS program defines various levels of physical and data encryption security that devices must meet in order to operate on Federal wireless networks. The FIPS 140-2 standard is designed to protect sensitive but unclassified information, such as electronic health records. CareFusion's Alaris® Systems Manager facilitates wireless communications between the Alaris infusion pump system and a hospital's wireless network to provide an enterprise-grade, secure deployment architecture.

"We've been helping the VA network of hospitals deliver quality care for many years," said JC Kyrillos, senior vice president and general manager of Infusion Systems at CareFusion. "This federal certification underscores CareFusion's commitment to advanced technology that is designed to protect patient safety and confidentiality. In the event this wireless security requirement extends to other Federal care providers, we are well positioned and ready to support provider needs."

The Alaris System is a comprehensive IV medication delivery system and the only such technology now compliant with FIPS 140-2. The Alaris System is a modular infusion platform that integrates a single, point-of-care unit featuring Guardrails® Suite MX safety software with large volume pump, Patient Controlled Analgesia, respiratory monitoring (SpO2 and EtCO2) syringe and barcoding capabilities across all infusion modalities. The Alaris System combined with the Alaris Systems Manager helps improve safety and reduce costs as part of an integrated system that helps streamline workflow and wirelessly manages and transfers infusion data.

About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at www.carefusion.com.


'/>"/>
SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition
2. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
3. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
4. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
5. CareFusion Moves First Quarter Earnings Announcement to November 5
6. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
7. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
8. CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology
9. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
10. CareFusion Will Host an Earnings Conference Call on Feb. 9 to Discuss the Results for the Second Quarter of Fiscal 2010
11. FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
(Date:4/20/2017)... Research and Markets has announced the ... Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market ... Low drug registration cost in Latin American countries and ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... SALT LAKE CITY, UTAH (PRWEB) , ... April ... ... Josée Côté as Account Manager for the North East region. Côté has 20+ ... operations and consulting. Prior to Phytomer, Côté worked with an array of high-end ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly ... the premier online modeling resource for fluorescence microscopists and optical system designers, enabling ... last 5 years spanning the globe, SearchLight has become a tremendously popular tool ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
Breaking Medicine News(10 mins):